Nancy Simonian
2022
In 2022, Nancy Simonian earned a total compensation of $3.5M as President & Chief Executive Officer at Syros Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $316,800 |
|---|---|
| Option Awards | $974,802 |
| Salary | $636,615 |
| Stock Awards | $1,557,683 |
| Other | $1,980 |
| Total | $3,487,880 |
Simonian received $1.6M in stock awards, accounting for 45% of the total pay in 2022.
Simonian also received $316.8K in non-equity incentive plan, $974.8K in option awards, $636.6K in salary and $2K in other compensation.
Rankings
In 2022, Nancy Simonian's compensation ranked 1,021st out of 5,538 executives tracked by ExecPay. In other words, Simonian earned more than 81.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,021 out of 5,538 | 82nd |
Division Manufacturing | 477 out of 3,000 | 84th |
Major group Chemicals And Allied Products | 170 out of 1,350 | 87th |
Industry group Drugs | 153 out of 1,253 | 88th |
Industry Pharmaceutical Preparations | 113 out of 907 | 88th |
Source: SEC filing on April 21, 2023.
Simonian's colleagues
We found two more compensation records of executives who worked with Nancy Simonian at Syros Pharmaceuticals in 2022.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019